Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo

Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo

Jiaxuan Peng,1,* Kangxian Zhao,2,* Jiling Zhu,3,* Yanben Wang,4,5 Peng Sun,2 Qichang Yang,2 Tan Zhang,4 Weiqi Han,4 Wenjun Hu,4 Wanlei Yang,4 Jianwei Ruan,6 Yu Qian1,2,4 1Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Guangxi 530021, People’s Republic of China...

Full description

Bibliographic Details
Main Authors: Peng J, Zhao K, Zhu J, Wang Y, Sun P, Yang Q, Zhang T, Han W, Hu W, Yang W, Ruan J, Qian Y
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Drug Design, Development and Therapy
Subjects:
sarsasapogenin
osteoclast
osteoclastogenesis
nf-κb
mapk
nfatc1
therapeutics
Online Access:https://www.dovepress.com/sarsasapogenin-suppresses-rankl-induced-osteoclastogenesis-in-vitro-an-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/sarsasapogenin-suppresses-rankl-induced-osteoclastogenesis-in-vitro-an-peer-reviewed-article-DDDT

Similar Items